TSC1 and TSC2-mutant cells thus have constitutively increased activity of mTOR kinase, which likely underlies the abnormal proliferation and differentiation of cells suspected to occur in multiple organs of patients with TSC [34]. The gene discussed is TSC2; the disease is tuberous sclerosis.